A common pathway is semaglutide as an introduction, tirzepatide for patients who plateau or want stronger results, and retatrutide for patients who plateau on tirzepatide
The TRIUMPH-4 data are part of an ongoing Phase III program, and regulatory submissions to the FDA and other agencies have not yet been completed
GIP + GLP-1 refers to a new generation of weight-loss medications that combine two powerful gut-derived hormones: Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1)
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE maintenance randomized study
Caroline Apovian, the co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital, agrees: "The studies show over and over and over again," Apovian says, that if you stop taking the medications, "you will regain the weight back." Noom isn't the only startup to market GLP-1s as temporary treatments that offer long-term effects
Proper storage and handling practices help preserve product integrity, stability, and overall quality
